By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Karolinska Development AB 

Fogdevreten 2, Solna

Stockholm    S-171 77  Sweden
Phone: 46-0-8-524-865-91 Fax: n/a



Company News
Karolinska Development AB Notes Oncopeptides' Successful Listing On Nasdaq Stockholm - Company's Earn-Out Has A Current Market Value Of SEK 26.7 Million 2/24/2017 7:37:27 AM
Karolinska Development AB Divests Its Holding In Inhalation Sciences 2/13/2017 8:20:10 AM
Karolinska Development AB — Offer On A Set-Off Share Issue To Convertible Holders To Strengthen The Company’s Equity Position 2/7/2017 7:34:11 AM
Notice Of Extraordinary General Meeting In Karolinska Development AB 2/7/2017 7:05:12 AM
Karolinska Development AB Release: Pharma Portfolio Company OssDsign Announces FDA 510(K) Clearance For Marketing Of OSSDSIGN Cranial For Sale In The U.S.A. 1/20/2017 9:33:12 AM
Karolinska Development AB Release: Company Portfolio Company Promimic AB Appoints Magnus Larsson As New CEO And Launches US Sales Operation 1/18/2017 12:47:33 PM
Karolinska Development AB Portfolio Company Dilafor Initiates Phase IIb Clinical Trial With Tafoxiparin In Women With Protracted Labor 1/4/2017 8:43:21 AM
Karolinska Development AB Company Modus To Present Poster At 58th American Society of Hematology Annual Meeting In San Diego 12/1/2016 9:06:54 AM
Karolinska Development AB: Interim Report For January-September 2016 11/23/2016 9:06:04 AM
Karolinska Development AB – Q3 2016 Interim Report - Invitation To Conference Call And Webcast 11/17/2016 11:11:27 AM